Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM ISTCovaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech17 Jun, 2022, 12.15 PM ISTCoronavirus vaccine: ICMR partners with BBIL to develop indigenous COVID-19 vaccine09 May, 2020, 08.37 PM ISTThis hellish planet is so hot it has clouds of glass and an atmosphere of vaporized metal
Home sales fall to three-year low in June quarter
Espire Hospitality posts revenue of Rs 141 crore for FY26, PAT at Rs 8 crore
Legacy studios bet on mobile-first entertainment for next growth phase
US fixed-term student visas may hit Indian enrolments
In Graphics: Europe searches for ACs in soaring heat
Draft National Electricity Data Sharing Framework unveiled
Money can't buy success in World Cup for gulf nations like Saudi Arabia and Qatar
Power demand tops 250 GW as weak monsoon keeps heat on
India-Israel, GCC FTA talks temporarily stalled due to West Asia crisis: Piyush Goyal
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service